These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3651725)

  • 1. Switch mechanism in affective illness and oral S-adenosylmethionine (SAM).
    Carney MW; Chary TK; Bottiglieri T; Reynolds EH; Toone BK
    Br J Psychiatry; 1987 May; 150():724-5. PubMed ID: 3651725
    [No Abstract]   [Full Text] [Related]  

  • 2. Switch mechanism in affective illness and S-adenosylmethionine.
    Carney MW; Martin R; Bottiglieri T; Reynolds EH; Nissenbaum H; Toone BK; Sheffield BN
    Lancet; 1983 Apr; 1(8328):820-1. PubMed ID: 6132153
    [No Abstract]   [Full Text] [Related]  

  • 3. Cerebrospinal fluid S-adenosylmethionine in depression and dementia: effects of treatment with parenteral and oral S-adenosylmethionine.
    Bottiglieri T; Godfrey P; Flynn T; Carney MW; Toone BK; Reynolds EH
    J Neurol Neurosurg Psychiatry; 1990 Dec; 53(12):1096-8. PubMed ID: 2292704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral S-adenosylmethionine in depression: a randomized, double-blind, placebo-controlled trial.
    Kagan BL; Sultzer DL; Rosenlicht N; Gerner RH
    Am J Psychiatry; 1990 May; 147(5):591-5. PubMed ID: 2183633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An open-label pilot study of oral S-adenosyl-L-methionine in major depression: interim results.
    Rosenbaum JF; Fava M; Falk WE; Pollack MH; Cohen LS; Cohen BM; Zubenko GS
    Psychopharmacol Bull; 1988; 24(1):189-94. PubMed ID: 3387521
    [No Abstract]   [Full Text] [Related]  

  • 6. Open trial of S-adenosylmethionine for treatment of depression.
    Lipinski JF; Cohen BM; Frankenburg F; Tohen M; Waternaux C; Altesman R; Jones B; Harris P
    Am J Psychiatry; 1984 Mar; 141(3):448-50. PubMed ID: 6367496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S-adenosylmethionine treatment of depression: a controlled clinical trial.
    Bell KM; Plon L; Bunney WE; Potkin SG
    Am J Psychiatry; 1988 Sep; 145(9):1110-4. PubMed ID: 3046382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Switch and S-adenosylmethionine.
    Carney MW; Chary TK; Bottiglieri T; Reynolds EH
    Ala J Med Sci; 1988 Jul; 25(3):316-9. PubMed ID: 3052141
    [No Abstract]   [Full Text] [Related]  

  • 9. The switch mechanism and the bipolar/unipolar dichotomy.
    Carney MW; Chary TK; Bottiglieri T; Reynolds EH
    Br J Psychiatry; 1989 Jan; 154():48-51. PubMed ID: 2673478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An open-label pilot study of oral S-adenosylmethionine in major depression. An interim report.
    Rosenbaum JF; Fava M; Falk WE; Pollack MH; Cohen LS; Cohen BM; Zubenko GS
    Ala J Med Sci; 1988 Jul; 25(3):301-6. PubMed ID: 3052138
    [No Abstract]   [Full Text] [Related]  

  • 11. Oral SAMe in persistent treatment-refractory bipolar depression: a double-blind, randomized clinical trial.
    Murphy BL; Babb SM; Ravichandran C; Cohen BM
    J Clin Psychopharmacol; 2014 Jun; 34(3):413-6. PubMed ID: 24699040
    [No Abstract]   [Full Text] [Related]  

  • 12. The influence of S-adenosylmethionine (SAM) on prolactin in depressed patients.
    Thomas CS; Bottiglieri T; Edeh J; Carney MW; Reynolds EH; Toone BK
    Int Clin Psychopharmacol; 1987 Apr; 2(2):97-102. PubMed ID: 3298421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Affective illness and S-adenosyl methionine: a preliminary report.
    Carney MW; Edeh J; Bottiglieri T; Reynolds EM; Toone BK
    Clin Neuropharmacol; 1986; 9(4):379-85. PubMed ID: 2425961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical evaluation of the antidepressive action of sulfoadenosyl-L-methionine compared with that of chlorimipramine].
    Giner Ubago J; González Infante JM; Blanco Picabia A
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1984; 12(1):73-80. PubMed ID: 6372376
    [No Abstract]   [Full Text] [Related]  

  • 15. Folic acid, S-adenosylmethionine and affective disorder.
    Reynolds EH; Stramentinoli G
    Psychol Med; 1983 Nov; 13(4):705-10. PubMed ID: 6141581
    [No Abstract]   [Full Text] [Related]  

  • 16. S-adenosylmethionine in depression. A literature review and preliminary report.
    Janicak PG; Lipinski J; Davis JM; Comaty JE; Waternaux C; Cohen B; Altman E; Sharma RP
    Ala J Med Sci; 1988 Jul; 25(3):306-13. PubMed ID: 3052139
    [No Abstract]   [Full Text] [Related]  

  • 17. Antidepressant activity of S-adenosylmethionine.
    Caruso I; Fumagalli M; Boccassini L; Sarzi Puttini P; Ciniselli G; Cavallari G
    Lancet; 1984 Apr; 1(8382):904. PubMed ID: 6143204
    [No Abstract]   [Full Text] [Related]  

  • 18. S-adenosylmethionine and affective disorder.
    Carney MW; Toone BK; Reynolds EH
    Am J Med; 1987 Nov; 83(5A):104-6. PubMed ID: 3318437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Controlled double-blind study (SAMe-imipramine) in depressive syndromes].
    Mantero M; Pastorino P; Carolei A; Agnoli A
    Minerva Med; 1975 Nov; 66(78):4098-101. PubMed ID: 1103017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic effects and mechanism of action of S-adenosyl-L-methionine (SAM) in depressive syndromes].
    Fazio C; Andreoli V; Agnoli A; Casacchia M; Cerbo R
    Minerva Med; 1973 Apr; 64(29):1515-29. PubMed ID: 4576704
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.